Voltage-gated sodium channel inhibitor

This page covers all Voltage-gated sodium channel inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-gated sodium channels (Nav).

Targets

Voltage-gated sodium channels (Nav)

Phase 3 pipeline (1)

• ESL - Part II · Bial - Portela C S.A. · Neurology
  ESL (eslicarbazepine acetate) is a voltage-gated sodium channel blocker that reduces neuronal excitability to prevent seizures.

Patent intelligence

• voltage gated sodium channel inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates